These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

315 related items for PubMed ID: 9500529

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3. Inhibition of IkappaB-alpha and IkappaB-beta proteolysis by calpain inhibitor I blocks nitric oxide synthesis.
    Milligan SA, Owens MW, Grisham MB.
    Arch Biochem Biophys; 1996 Nov 15; 335(2):388-95. PubMed ID: 8914937
    [Abstract] [Full Text] [Related]

  • 4. Amiloride blockades lipopolysaccharide-induced proinflammatory cytokine biosynthesis in an IkappaB-alpha/NF-kappaB-dependent mechanism. Evidence for the amplification of an antiinflammatory pathway in the alveolar epithelium.
    Haddad JJ, Land SC.
    Am J Respir Cell Mol Biol; 2002 Jan 15; 26(1):114-26. PubMed ID: 11751211
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. An anti-rheumatic agent T-614 inhibits NF-kappaB activation in LPS- and TNF-alpha-stimulated THP-1 cells without interfering with IkappaBalpha degradation.
    Aikawa Y, Yamamoto M, Yamamoto T, Morimoto K, Tanaka K.
    Inflamm Res; 2002 Apr 15; 51(4):188-94. PubMed ID: 12058956
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. 4-Hydroxynonenal prevents NF-kappaB activation and tumor necrosis factor expression by inhibiting IkappaB phosphorylation and subsequent proteolysis.
    Page S, Fischer C, Baumgartner B, Haas M, Kreusel U, Loidl G, Hayn M, Ziegler-Heitbrock HW, Neumeier D, Brand K.
    J Biol Chem; 1999 Apr 23; 274(17):11611-8. PubMed ID: 10206970
    [Abstract] [Full Text] [Related]

  • 9. Proteasome inhibitors induce inhibitory kappa B (I kappa B) kinase activation, I kappa B alpha degradation, and nuclear factor kappa B activation in HT-29 cells.
    Németh ZH, Wong HR, Odoms K, Deitch EA, Szabó C, Vizi ES, Haskó G.
    Mol Pharmacol; 2004 Feb 23; 65(2):342-9. PubMed ID: 14742676
    [Abstract] [Full Text] [Related]

  • 10. Tumor necrosis factor-alpha-inducible IkappaBalpha proteolysis mediated by cytosolic m-calpain. A mechanism parallel to the ubiquitin-proteasome pathway for nuclear factor-kappab activation.
    Han Y, Weinman S, Boldogh I, Walker RK, Brasier AR.
    J Biol Chem; 1999 Jan 08; 274(2):787-94. PubMed ID: 9873017
    [Abstract] [Full Text] [Related]

  • 11. Anti-inflammatory effects of moxifloxacin on activated human monocytic cells: inhibition of NF-kappaB and mitogen-activated protein kinase activation and of synthesis of proinflammatory cytokines.
    Weiss T, Shalit I, Blau H, Werber S, Halperin D, Levitov A, Fabian I.
    Antimicrob Agents Chemother; 2004 Jun 08; 48(6):1974-82. PubMed ID: 15155187
    [Abstract] [Full Text] [Related]

  • 12. Transient nuclear factor kappaB (NF-kappaB) activation stimulated by interleukin-1beta may be partly dependent on proteasome activity, but not phosphorylation and ubiquitination of the IkappaBalpha molecule, in C6 glioma cells. Regulation of NF-kappaB linked to chemokine production.
    Uehara T, Matsuno J, Kaneko M, Nishiya T, Fujimuro M, Yokosawa H, Nomura Y.
    J Biol Chem; 1999 May 28; 274(22):15875-82. PubMed ID: 10336492
    [Abstract] [Full Text] [Related]

  • 13. Endotoxin stress-response in cardiomyocytes: NF-kappaB activation and tumor necrosis factor-alpha expression.
    Wright G, Singh IS, Hasday JD, Farrance IK, Hall G, Cross AS, Rogers TB.
    Am J Physiol Heart Circ Physiol; 2002 Mar 28; 282(3):H872-9. PubMed ID: 11834481
    [Abstract] [Full Text] [Related]

  • 14. Interleukin-10 stabilizes inhibitory kappaB-alpha in human monocytes.
    Shames BD, Selzman CH, Meldrum DR, Pulido EJ, Barton HA, Meng X, Harken AH, McIntyre RC.
    Shock; 1998 Dec 28; 10(6):389-94. PubMed ID: 9872676
    [Abstract] [Full Text] [Related]

  • 15. Butyrate suppression of colonocyte NF-kappa B activation and cellular proteasome activity.
    Yin L, Laevsky G, Giardina C.
    J Biol Chem; 2001 Nov 30; 276(48):44641-6. PubMed ID: 11572859
    [Abstract] [Full Text] [Related]

  • 16. Ubiquitin/proteasome-dependent degradation of D-type cyclins is linked to tumor necrosis factor-induced cell cycle arrest.
    Hu X, Bryington M, Fisher AB, Liang X, Zhang X, Cui D, Datta I, Zuckerman KS.
    J Biol Chem; 2002 May 10; 277(19):16528-37. PubMed ID: 11864973
    [Abstract] [Full Text] [Related]

  • 17. MG132 proteasome inhibitor modulates proinflammatory cytokines production and expression of their receptors in U937 cells: involvement of nuclear factor-kappaB and activator protein-1.
    Ortiz-Lazareno PC, Hernandez-Flores G, Dominguez-Rodriguez JR, Lerma-Diaz JM, Jave-Suarez LF, Aguilar-Lemarroy A, Gomez-Contreras PC, Scott-Algara D, Bravo-Cuellar A.
    Immunology; 2008 Aug 10; 124(4):534-41. PubMed ID: 18298552
    [Abstract] [Full Text] [Related]

  • 18. Proteasome inhibitors up-regulate haem oxygenase-1 gene expression: requirement of p38 MAPK (mitogen-activated protein kinase) activation but not of NF-kappaB (nuclear factor kappaB) inhibition.
    Wu WT, Chi KH, Ho FM, Tsao WC, Lin WW.
    Biochem J; 2004 May 01; 379(Pt 3):587-93. PubMed ID: 14731112
    [Abstract] [Full Text] [Related]

  • 19. Inhibition of NFkappaB in activated rat hepatic stellate cells by proteasome inhibitors and an IkappaB super-repressor.
    Hellerbrand C, Jobin C, Iimuro Y, Licato L, Sartor RB, Brenner DA.
    Hepatology; 1998 May 01; 27(5):1285-95. PubMed ID: 9581682
    [Abstract] [Full Text] [Related]

  • 20. A pyrrolidinone derivative inhibits cytokine-induced iNOS expression and NF-kappaB activation by preventing phosphorylation and degradation of IkappaB-alpha.
    Katsuyama K, Hirata Y.
    J Biochem; 2001 Apr 01; 129(4):585-91. PubMed ID: 11275558
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 16.